E
EDIT
Editas Medicine Inc
2.645
-0.065-2.40%After Hours: 2.630 -0.015 -0.57%19:12 06/08 EDT
OPEN/PREV CLOSE2.760/2.710
TODAY RANGE2.610-2.760
VOL1.48M
MARKET CAP405.91M
52 WEEK RANGE1.660-4.537
AVG VOL (3M)2.04M
% TURNOVER0.96%
TURNOVER--
P/E (TTM)-2.1638
% RANGE5.54%
EPS(TTM)-1.2224
P/E(FORWARD)-2.4836
P/B58.78
BVPS0.0450
DIVIDEND--
P/S6.39
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP405.14M
SHARES OUTSTANDING153.46M
NEXT EARNINGS08/10-08/14
FREE FLOAT153.17M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
The Motley Fool·05/31 16:31
CRISPR Therapeutics vs. Editas Medicine: Which Gene Editing Stock Is a Better Buy in 2026?
Seeking Alpha·05/28 11:18
Editas Medicine: Resetting Pipeline Just To Be Second To Market Again
TipRanks·05/27 16:33
Editas Medicine preclinical data ‘looks highly supportive,’ says Evercore ISI
TipRanks·05/27 16:16
TD Cowen remains bullish on Editas Medicine after ‘compelling preclinical data’
Benzinga·05/27 14:51
Abercrombie & Fitch Upbeat Q1 Earnings, Joins Digital Turbine, Dycom Industries And Other Big Stocks Moving Higher On Wednesday
TipRanks·05/26 21:52
Editas Medicine Raises Capital Through Public Equity Offering
NASDAQ·05/26 18:14
Editas Medicine Prices Up To $319.4 Million Public Offering
Reuters·05/26 14:05
BUZZ-Editas Medicine down after $125 mln stock-and-warrants offering
TipRanks·05/26 13:43
Editas Medicine 55.6M share Secondary priced at $2.25
Reuters·05/26 13:30
NASDAQ TRADE HALT <EDIT.O> VOLATILITY TRADING PAUSE AT 09:30 AM
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.